News and viewMyocardial β-adrenergic receptor downregulation in heart failure☆
References (20)
- et al.
Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol
Am Heart J
(1983) - et al.
Plasma norepinephrine in congestive heart failure
Am J Cardiol
(1978) - et al.
Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure
Am Heart J
(1982) - et al.
Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure
Am J Med
(1965) - et al.
Elevated left ventricular myocardial dopamine in preterminal idiopathic dilated cardiomyopathy
Am J Cardiol
(1983) - et al.
Beneficial effects of long-term beta-blockade in congestive cardiomyopathy
Br Heart J
(1980) - et al.
Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts
N Engl J Med
(1982) - et al.
Effects of the H2-receptor agonist impromidine in human myocardium from patients with heart failure due to mitral and aortic valve disease
J Cardiovasc Pharmacol
(1983) - et al.
Histamine-mediated adenylate cyclase stimulation in human myocardium
Mol Pharmacol
(1982) - et al.
Myocardial performance and extracellular ionized calcium in a severely failing human heart
Ann Intern Med
(1983)
Cited by (50)
The historical evolution of knowledge of the involvement of neurohormonal systems in the pathophysiology and treatment of heart failure
2019, Revista Portuguesa de CardiologiaAKAP150 participates in calcineurin/NFAT activation during the down-regulation of voltage-gated K<sup>+</sup> currents in ventricular myocytes following myocardial infarction
2016, Cellular SignallingCitation Excerpt :Anomalies in the β adrenergic signaling cascade are linked to altered regulation of [Ca2 +]i in ventricular myocytes [26,27]. Although acute activation of β adrenergic receptors (βAR) can increase heart function, a well-known and long standing paradox is that chronic activation of the same signaling cascade causes hypertrophy, electrical remodeling, and arrhythmogenesis after myocardial infarction [28–30]. Likewise, NFAT mediated transcriptional remodeling is a critical event in certain heart diseases including the attenuation of KV channel function that is associated with QT prolongation and increased susceptibility to arrhythmia [6].
Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology
2016, GeneCitation Excerpt :Given its prominent role in normal physiology it is not surprising that there has been much interest in how PKA phosphorylation goes wrong in disease (Esseltine and Scott, 2013). Probably the most common pathological effects of defective cAMP signaling underlie the onset of coronary heart disease and cardiomyopathies (Bristow et al., 1982, 1984; Bristow, 1984; Diviani et al., 2011). It has been known since the early 1960's that blocking β adrenergic stimulation of cAMP synthesis is protective against heart disease (Black and Stephenson, 1962).
UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy
2015, Cellular SignallingCitation Excerpt :Importantly, AKAPs target signaling complexes to distinct subcellular locations, thereby generating signaling specificity [31–33]. AKAPs perform a critical role in mediating the effects of neurohumoral stimulation of the heart by integrating PKA activity with additional enzymes [34–36]. Previously, we and others have demonstrated a critical role for AKAP–Lbc in hypertrophy induction [37–39].
Activation of the Adrenergic Nervous System in Heart Failure
2011, Heart FailureActivation of the Adrenergic Nervous System in Heart Failure
2010, Heart Failure: A Companion to Braunwald's Heart Disease Expert Consult
- ☆
From the Cardiology Division, University of Utah School of Medicine, Salt Lake City, Utah, and the Department of Cardiovascular Surgery, Stanford University Medical Center, Stanford, California.